Young people who start vaping may become deeply dependent and suffer intense withdrawal, often finding it harder to quit than cigarettes
The rise of e-cigarettes among young people has created a public health concern that goes beyond questions of relative safety. While many clinicians view vaping as a less harmful alternative for established smokers, an increasing number of adolescents and young adults who never smoked are adopting the habit.
Research and clinical reports now show that this can lead to entrenched vaping addiction and pronounced nicotine withdrawal when users attempt to stop. The pattern is driven in part by convenience and social factors that make vaping easier to do frequently than traditional smoking.
What follows is a synthesis of evidence, clinician observations and personal experience to explain why quitting can be unexpectedly difficult, what symptoms people commonly report and which support options are showing promise. Throughout this article, key terms such as nicotine withdrawal and varenicline are highlighted, and definitions or specific clinical concepts are set in italics so readers can quickly spot essential information.
Why vaping is so likely to create dependence
One major driver of dependence is the combination of high nicotine delivery and the ability to vape almost anywhere. Many users report that they take puffs more frequently because e-cigarettes are easier to use indoors and in social settings, increasing overall nicotine exposure compared with smoking. Public data indicate around 5.4 million people in the UK now vape, and surveys show that a growing share of young people have experimented with devices despite age restrictions. Studies also report that younger vapers tend to attempt quitting repeatedly but often fail, suggesting that initial experimentation can evolve into a persistent habit.
Clinical accounts and qualitative research underline the intensity of the problem: in a 2026 US study of 18-to-24-year-olds, nearly three-quarters had tried and failed to stop vaping, and about half of those had failed on multiple occasions. Participants described symptoms that ranged from crippling tiredness and low motivation to severe irritability and shaking—classical markers of withdrawal syndrome. Together, these findings help explain why what begins as trial use can quickly become a cycle of dependence and repeated failed cessation attempts.
How withdrawal compares with quitting cigarettes
For some people, stopping vaping can feel harder than quitting combustible tobacco. Clinicians observe that the constant opportunity to use an e-cigarette encourages more frequent dosing of nicotine, intensifying dependence. Dr Aran Singanayagam, a respiratory medicine consultant, notes that patients often report feeling “terrible” during quit attempts: pervasive anxiety, restlessness and mood swings are common. These symptoms are characteristic of nicotine withdrawal, and for many vapers they are severe because the behavioral cues—hand-to-mouth action, flavored aerosols and social reinforcement—remain readily available in daily life.
Personal accounts mirror medical observations. One former user, a 33-year-old fitness professional from London, described long-term vaping after switching from cigarettes on medical advice. She said she consumed an amount of nicotine equivalent to dozens of cigarettes per day via disposables, took them during long runs and found the withdrawal period when quitting to be emotionally and physically draining. Despite feeling healthier after stopping, she still experiences occasional cravings, a reminder that recovery from addiction can be gradual.
Health context and broader risks
It is important to balance relative risk messages: while evidence shows that smoking remains the dominant cause of lung cancer—killing tens of thousands annually in the UK—taking up vaping is not risk-free. The convenience of vaping has contributed to its uptake among underage groups; surveys indicate one in five British children aged 11 to 17 have tried vaping, even though sales to under-18s are illegal. Early initiation increases the likelihood of sustained use and complicates later cessation.
Practical quitting methods and medical options
Quitting strategies often combine behavioral changes with pharmacological support. The NHS recommends stepwise reduction: lower the nicotine strength in refill liquids and prolong intervals between puffs to gradually reduce dependence. Such tapering aims to lessen the intensity of withdrawal symptoms, although it rarely eliminates them entirely. Behavioral substitutions—chewing sugar-free gum, holding a small object, or using oral alternatives—can also reduce the urge to vape by replacing the hand-to-mouth ritual.
Pharmacological aids show promise as well. A major study published last year reported that daily varenicline helped roughly half of young vapers (aged 16–25) to quit, compared with a significantly lower success rate on placebo. Despite these encouraging results, the NHS currently does not routinely prescribe varenicline specifically for vaping cessation. Clinicians and patients exploring medical support should consult their GP to discuss licensed options and individualized plans.
Simple, low-tech tools that helped people quit
Many former vapers credit small behavioral tools with helping them resist cravings. For some, flavored toothpicks or sugar-free lollipops provided a discreet oral alternative and a tactile substitute for the vape device, easing the early weeks of withdrawal. While these items do not address the underlying physiological dependence, they can be a useful part of a wider quit plan that includes gradual nicotine reduction, counseling and medical review.
Final advice for anyone considering vaping
For people weighing the decision to vape—especially those who have never smoked—the evidence suggests caution. The combination of high nicotine exposure, ubiquitous use opportunities and robust behavioral reinforcement can produce an entrenched habit that is difficult to break. If you vape and want to quit, acknowledge that withdrawal can be strong, seek medical advice, consider structured tapering and explore both behavioral substitutions and licensed pharmacotherapy. For parents and policymakers, the key message is that preventing early uptake remains essential to avoid long-term dependence among young people.
